(Total Views: 315)
Posted On: 09/09/2020 6:02:45 PM
Post# of 36567
Speaking of NGIO shares, I know someone brought this up previously, but did anyone get to the bottom of the extra 300,000 shares that the GNBT S1/A (Sept 3) showed NGIO has outstanding?
"NuGenerex Immuno-Oncology, Inc. (“NGIO”), a Delaware corporation and subsidiary of Generex, has 750,000,000 authorized shares of common stock, 400,300,000 of which are outstanding, and prior to two stock dividends completed by Generex, were all held by Generex."
"NuGenerex Immuno-Oncology, Inc. (“NGIO”), a Delaware corporation and subsidiary of Generex, has 750,000,000 authorized shares of common stock, 400,300,000 of which are outstanding, and prior to two stock dividends completed by Generex, were all held by Generex."
(0)
(0)
